Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer

Panagiotis A. Konstantinopoulos, Allison A. Gockley, Niya Xiong, Carolyn Krasner, Neil Horowitz, Susana Campos, Alexi A. Wright, Joyce F. Liu, Meghan Shea, Oladapo Yeku, Cesar Castro, Madeline Polak, Elizabeth K. Lee, Hannah Sawyer, Brittany Bowes, John Moroney, Su-Chun Cheng, Nabihah Tayob, Sara Bouberhan, David Spriggs, Richard T. Penson, Gini F. Fleming, Marisa R. Nucci, Ursula A. Matulonis

Open source

DOI: 10.1001/jamaoncol.2022.2181
Published: 2022-09-01
Container: JAMA Oncology
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2022.2181,
  title = {Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer},
  author = {Panagiotis A. Konstantinopoulos and Allison A. Gockley and Niya Xiong and Carolyn Krasner and Neil Horowitz and Susana Campos and Alexi A. Wright and Joyce F. Liu and Meghan Shea and Oladapo Yeku and Cesar Castro and Madeline Polak and Elizabeth K. Lee and Hannah Sawyer and Brittany Bowes and John Moroney and Su-Chun Cheng and Nabihah Tayob and Sara Bouberhan and David Spriggs and Richard T. Penson and Gini F. Fleming and Marisa R. Nucci and Ursula A. Matulonis},
  year = {2022},
  journal = {JAMA Oncology},
  doi = {10.1001/jamaoncol.2022.2181},
  url = {https://doi.org/10.1001/jamaoncol.2022.2181}
}

RIS

TY  - JOUR
TI  - Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
AU  - Panagiotis A. Konstantinopoulos
AU  - Allison A. Gockley
AU  - Niya Xiong
AU  - Carolyn Krasner
AU  - Neil Horowitz
AU  - Susana Campos
AU  - Alexi A. Wright
AU  - Joyce F. Liu
AU  - Meghan Shea
AU  - Oladapo Yeku
AU  - Cesar Castro
AU  - Madeline Polak
AU  - Elizabeth K. Lee
AU  - Hannah Sawyer
AU  - Brittany Bowes
AU  - John Moroney
AU  - Su-Chun Cheng
AU  - Nabihah Tayob
AU  - Sara Bouberhan
AU  - David Spriggs
AU  - Richard T. Penson
AU  - Gini F. Fleming
AU  - Marisa R. Nucci
AU  - Ursula A. Matulonis
PY  - 2022
JO  - JAMA Oncology
DO  - 10.1001/jamaoncol.2022.2181
UR  - https://doi.org/10.1001/jamaoncol.2022.2181
ER  -

APA

Konstantinopoulos, P. A., Gockley, A. A., Xiong, N., Krasner, C., Horowitz, N., Campos, S., Wright, A. A., Liu, J. F., Shea, M., Yeku, O., Castro, C., Polak, M., Lee, E. K., Sawyer, H., Bowes, B., Moroney, J., Cheng, S., Tayob, N., Bouberhan, S., Spriggs, D., Penson, R. T., Fleming, G. F., Nucci, M. R., & Matulonis, U. A. (2022). Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2022.2181

Source records

crossref · retrieved 2026-09-25T23:29:23.869Z